Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Eukaryotic Gene Expression
Facteur d'impact: 1.841 Facteur d'impact sur 5 ans: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimer: 1045-4403
ISSN En ligne: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2018025121
pages 373-384

Interferon-Free Regimen for Hepatitis C: Insight and Management

Muhammad Shareef Masoud
Department of Bioinformatics and Biotechnology, Government College University Faisalabad (GCUF), Pakistan
Usman Ali Ashfaq
Department of Bioinformatics & Biotechnology, Government College University, 38000 Faisalabad, Pakistan
Hina Khalid
Department of Bioinformatics and Biotechnology, Government College University Faisalabad (GCUF), Pakistan


The rapid development of direct-acting antiviral agents (DAA) for hepatitis C virus (HCV) therapy dramatically altered the treatment landscape of this disease. The DAA regimen is associated with various advantages including high sustained virological response (SVR) with minimum side effects and low pill load and specific inhibition of viral replication, which lowers dependence on the host cell. This regimen has substantially replaced conventional (interferon) therapy with high cure rates (> 90%) in most HCV populations. This review provides insight into clinical studies of NS3/4A protease inhibitors, NS5B viral polymerase inhibitor (nucleotide and non-nucleotide), and NS5A inhibitors, alone and in combination.

Articles with similar content:

Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Manuela Labbozzetta, Nicoletta Vivona, Paola Poma, Monica Notarbartolo, Natale D'Alessandro
Oral Controlled-Release Formulation in Veterinary Medicine
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.23, 2006, issue 3
Stefan Soback, Eran Lavy, Amir Steinman
Fibrin Sealants in Microvascular Surgery: Current Status
Journal of Long-Term Effects of Medical Implants, Vol.11, 2001, issue 1&2
Robert E. H. Ferguson, Jr., David B. Drake
Slip Slidin' Away: A Duodecen-nial Review of Targeted Genes in Mismatch Repair Deficient Colorectal Cancer
Critical Reviews™ in Oncogenesis, Vol.13, 2007, issue 3
Terje Ahlquist, Torbjorn Rognes, Ellen C. Royrvik, Ragnhild A. Lothe
Heparan Sulfate-based Treatments for Regenerative Medicine
Critical Reviews™ in Eukaryotic Gene Expression, Vol.21, 2011, issue 1
Victor Nurcombe, Bina Rai, Simon M. Cool